{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:51:43Z","timestamp":1779166303629,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T00:00:00Z","timestamp":1535587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T00:00:00Z","timestamp":1535587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim of this study was to investigate the diagnostic value of the platelet count-to-spleen volume ratio (PSR) for diagnosing hepatic fibrosis in patients with hepatocellular carcinoma (HCC). In this interim analysis of an on-going prospective study, 117 patients with HCC and with or without cirrhosis or fibrosis in different stages were analyzed. Fibrosis staging negatively correlated with PSR and the liver volume-to-spleen volume ratio (LSR), while it positively correlated with aspartate aminotransferase-to-platelet ratio index (APRI), Frons\u2019 index, S-index and a fibrosis index based on four factors (FIB-4). The area under the receiver operating characteristic curve (AUROC) was significantly larger for PSR (0.777) than LSR (0.633, <jats:italic>P<\/jats:italic>\u2009=\u20090.002). Among patients with significant fibrosis, AUROC for PSR did not differ significantly from the AUROCs for APRI (0.789, <jats:italic>P<\/jats:italic>\u2009=\u20090.825), Frons\u2019 index (0.674, <jats:italic>P<\/jats:italic>\u2009=\u20090.102), FIB-4 (0.704, <jats:italic>P<\/jats:italic>\u2009=\u20090.251) or S-index (0.696, <jats:italic>P<\/jats:italic>\u2009=\u20090.204). Among patients with severe fibrosis, AUROC was significantly higher for PSR (0.808) than for LSR (0.685, <jats:italic>P<\/jats:italic>\u2009=\u20090.003), Frons\u2019 index (0.673, <jats:italic>P<\/jats:italic>\u2009=\u20090.014), FIB-4 (0.684, <jats:italic>P<\/jats:italic>\u2009=\u20090.029), or S-index (0.672, <jats:italic>P<\/jats:italic>\u2009=\u20090.016); in contrast, the AUROC for PSR was not significantly different from that for APRI (0.739, <jats:italic>P<\/jats:italic>\u2009=\u20090.215). Among patients with cirrhosis, AUROC was significantly higher for PSR (0.814) than for LSR (0.671, <jats:italic>P<\/jats:italic>\u2009=\u20090.001) or S-index (0.679, <jats:italic>P<\/jats:italic>\u2009=\u20090.022), while the AUROC for PSR did not differ significantly from those for APRI (0.711, P\u2009=\u20090.105), Frons\u2019 index (0.722, <jats:italic>P<\/jats:italic>\u2009=\u20090.061) or FIB-4 (0.708, <jats:italic>P<\/jats:italic>\u2009=\u20090.079). Our results suggest that PSR may be a useful non-invasive model for diagnosing liver fibrosis stage in patients with HCC in China.<\/jats:p>","DOI":"10.1038\/s41598-018-31351-3","type":"journal-article","created":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T09:37:02Z","timestamp":1535103422000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A novel, non-invasive model for diagnosing liver fibrosis stage in patients with hepatocellular carcinoma"],"prefix":"10.1038","volume":"8","author":[{"given":"Gao-Xiong","family":"Ouyang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-Liang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Kai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bang-De","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le-Qun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,30]]},"reference":[{"key":"31351_CR1","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.3748\/wjg.v21.i13.3826","volume":"21","author":"HJ Yim","year":"2015","unstructured":"Yim, H. J., Suh, S. J. & Um, S. H. Current management of hepatocellular carcinoma: An Eastern perspective. World J Gastroenterol. 21, 3826\u20133842 (2015).","journal-title":"World J Gastroenterol."},{"key":"31351_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2174\/1568009616666160926124530","volume":"17","author":"SY Yan","year":"2017","unstructured":"Yan, S. Y., Fan, J. G. & Qio, L. Hepatitis B Virus (HBV) Infection and Hepatocellular Carcinoma- New Insights for an Old Topic. Curr cancer drug targets. 17, 505\u2013511 (2017).","journal-title":"Curr cancer drug targets."},{"key":"31351_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/hep.1840200104","volume":"20","author":"P Bedossa","year":"1994","unstructured":"Bedossa, P. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology. 20, 15\u201320 (1994).","journal-title":"Hepatology."},{"key":"31351_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/jhep.2000.16602","volume":"32","author":"JF Cadranel","year":"2000","unstructured":"Cadranel, J. F., Rufat, P. & Degos, F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology. 32, 477\u2013481 (2000).","journal-title":"Hepatology."},{"key":"31351_CR5","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","volume":"97","author":"A Regev","year":"2002","unstructured":"Regev, A. et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 97, 2614\u20132618 (2002).","journal-title":"Am J Gastroenterol."},{"key":"31351_CR6","doi-asserted-by":"publisher","first-page":"7089702","DOI":"10.1155\/2017\/7089702","volume":"2017","author":"T Ren","year":"2017","unstructured":"Ren, T., Wang, H., Wu, R. & Niu, J. Gamma-Glutamyl Transpeptidase-to-Platelet Ratio Predicts Significant Liver Fibrosis ofChronic Hepatitis B Patients in China. Gastroenterol Res Pract. 2017, 7089702\u20137089709 (2017).","journal-title":"Gastroenterol Res Pract."},{"key":"31351_CR7","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/j.1440-1746.2010.06383.x","volume":"25","author":"K Zhou","year":"2010","unstructured":"Zhou, K. et al. Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B. J Gastroenterol Hepatol. 25, 1569\u20131577 (2010).","journal-title":"J Gastroenterol Hepatol."},{"key":"31351_CR8","doi-asserted-by":"publisher","first-page":"e6336","DOI":"10.1097\/MD.0000000000006336","volume":"96","author":"Q Li","year":"2017","unstructured":"Li, Q. et al. Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT \u22642 ULN: A retrospective cohort study. Medicine. 96, e6336\u2013e6343 (2017).","journal-title":"Medicine."},{"key":"31351_CR9","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/hep.21334","volume":"44","author":"PA Vallet","year":"2006","unstructured":"Vallet, P. A., Vincent, M. V. & Pol, S. FIB4: A simple, inexpensive and accurate marker of fibrosis in HCVinfected patients. Hepatology. 44, 769\u2013770 (2006).","journal-title":"Hepatology."},{"key":"31351_CR10","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/hep.27382","volume":"61","author":"G Xiao","year":"2015","unstructured":"Xiao, G., Yang, J. & Yan, L. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis. Hepatology. 61, 292\u2013302 (2015).","journal-title":"Hepatology."},{"key":"31351_CR11","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jhep.2015.11.012","volume":"64","author":"WR Kim","year":"2016","unstructured":"Kim, W. R. et al. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients. J Hepatol. 64, 773\u2013780 (2016).","journal-title":"J Hepatol."},{"key":"31351_CR12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S1499-3872(13)60040-5","volume":"12","author":"NS Qian","year":"2013","unstructured":"Qian, N. S., Liao, Y. H., Cai, S. W., Raut, V. & Dong, J. H. Comprehensive application of modern technologies in precise liver resection. Hepatobiliary pancreatic dis Int. 12, 244\u2013250 (2013).","journal-title":"Hepatobiliary pancreatic dis Int."},{"key":"31351_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/MEG.0000000000000269","volume":"27","author":"SP Yan","year":"2015","unstructured":"Yan, S. P. et al. A new model combining the liver\/spleen volume ratio and classification of varices predicts HVPG in hepatitis B patients with cirrhosis. Eur J gastroenterol hepatol. 27, 335\u2013343 (2015).","journal-title":"Eur J gastroenterol hepatol."},{"key":"31351_CR14","doi-asserted-by":"publisher","first-page":"10184","DOI":"10.3748\/wjg.v21.i35.10184","volume":"21","author":"XL Chen","year":"2015","unstructured":"Chen, X. L. et al. Platelet count combined with right liver volume and spleen volume measured by magnetic resonance imaging for identifying cirrhosis and esophageal varices. World J Gastroenterol. 21, 10184\u201310191 (2015).","journal-title":"World J Gastroenterol."},{"key":"31351_CR15","doi-asserted-by":"publisher","first-page":"8949","DOI":"10.3748\/wjg.v22.i40.8949","volume":"22","author":"N Fujita","year":"2016","unstructured":"Fujita, N. et al. Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry. World J Gastroenterol. 22, 8949\u20138955 (2016).","journal-title":"World J Gastroenterol."},{"key":"31351_CR16","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.3748\/wjg.15.3298","volume":"15","author":"P Liu","year":"2009","unstructured":"Liu, P., Li, P., He, W. & Zhao, L. Q. Liver and spleen volume variations in patients with hepatic fibrosis. World J Gastroenterol. 15, 3298\u20133302 (2009).","journal-title":"World J Gastroenterol."},{"key":"31351_CR17","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/jmri.23758","volume":"36","author":"S Goshima","year":"2012","unstructured":"Goshima, S. et al. Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio. J Magn Reson Imaging. 36, 1148\u20131153 (2012).","journal-title":"J Magn Reson Imaging."},{"key":"31351_CR18","first-page":"251","volume":"19","author":"E Lotan","year":"2017","unstructured":"Lotan, E. et al. The Role of Liver Segment-to-Spleen Volume Ratio in the Staging of Hepatic Fibrosis in Patients with Hepatitis C Virus Infection. Isr Med Assoc J. 19, 251\u2013256 (2017).","journal-title":"Isr Med Assoc J."},{"key":"31351_CR19","doi-asserted-by":"crossref","first-page":"28641","DOI":"10.18632\/oncotarget.16162","volume":"8","author":"Q Li","year":"2017","unstructured":"Li, Q., Lu, C., Li, W., Huang, Y. & Chen, L. The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment ofliver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease. Oncotarget. 8, 28641\u201328649 (2017).","journal-title":"Oncotarget."},{"key":"31351_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/00004836-198504000-00012","volume":"7","author":"MR Fisher","year":"1985","unstructured":"Fisher, M. R. & Gore, R. M. Computed tomography in the evaluation of cirrhosis and portal hypertension. J Clin Gastroenterol. 7, 173\u2013181 (1985).","journal-title":"J Clin Gastroenterol."},{"key":"31351_CR21","doi-asserted-by":"publisher","first-page":"60D","DOI":"10.1155\/2000\/617428","volume":"14","author":"RM Peck","year":"2000","unstructured":"Peck, R. M. Thrombocytopenia in liver disease. Can J Gastroenterol. 14, 60D\u201366D (2000).","journal-title":"Can J Gastroenterol."},{"key":"31351_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ejim.2011.11.010","volume":"23","author":"S Esmat","year":"2012","unstructured":"Esmat, S., Omarn, D. & Rashid, L. Can we consider the right hepatic lobe size\/albumin ratio a noninvasive predictor of oesophageal varices in hepatitis C virus-related liver cirrhotic Egyptian patients? Eur J Int Med. 23, 267\u2013272 (2012).","journal-title":"Eur J Int Med."},{"key":"31351_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/hep.510310136","volume":"31","author":"EM Brunt","year":"2000","unstructured":"Brunt, E. M. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology. 31, 241\u2013246 (2000).","journal-title":"Hepatology."},{"key":"31351_CR24","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1136\/gutjnl-2015-309260","volume":"65","author":"M Lemoine","year":"2016","unstructured":"Lemoine, M. et al. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa. Gut. 65, 1369\u20131376 (2016).","journal-title":"Gut."},{"key":"31351_CR25","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1053\/jhep.2002.36128","volume":"36","author":"X Forns","year":"2002","unstructured":"Forns, X. et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology. 36, 986\u2013992 (2002).","journal-title":"Hepatology."},{"key":"31351_CR26","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1177\/0300060516664638","volume":"44","author":"RQ Wang","year":"2016","unstructured":"Wang, R. Q. et al. Gamma-glutamyl transpeptidase to platelet ratio index is a good noninvasive biomarker for predicting liver fibrosis in Chinese chronic hepatitis B patients. J Int Med Res. 44, 1302\u20131313 (2016).","journal-title":"J Int Med Res."},{"key":"31351_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/liv.13028","volume":"36","author":"A Sangiovanni","year":"2016","unstructured":"Sangiovanni, A. & Colombo, M. Treatment of hepatocellular carcinoma: beyond international guidelines. Liver Int. 36, 124\u2013129 (2016).","journal-title":"Liver Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31351-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31351-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31351-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T08:55:42Z","timestamp":1671612942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31351-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,30]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["31351"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-31351-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,30]]},"assertion":[{"value":"31 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13074"}}